Global Sites
Global / USA
Countries
Country Websites
Countries
Country Websites
Argentina
Argentina Site
Australia
Australia Site
Austria
Austria Site
Bahrain
Bangladesh
Barbados
Belgium
Belgium Site
Bolivia
Brazil
Brazil Site
Canada
Canada Site
Chile
Chile Site
China (Mainland)
China (Mainland) Site
Colombia
Colombia Site
Costa Rica
Czech Republic
Czech Republic Site
Denmark
Dominican Republic
Ecuador
Egypt
El Salvador
Finland
France
France Site
Germany
Germany Site
Greece
Guatemala
Honduras
Hong Kong (China)
Hungary
India
India Site
Indonesia
Ireland
Ireland Site
Israel
Italy
Italy Site
Jamaica
Japan
Japan Site
Jordan
Korea
Korea Site
Kuwait
Lebanon
Malaysia
Mexico
Mexico Site
Netherlands
Netherlands Site
New Zealand
New Zealand Site
Norway
Pakistan
Palestine
Panama
Peru
Philippines
Poland
Poland Site
Portugal
Portugal Site
Puerto Rico
Romania
Russia
Russia Site
Saudi Arabia
Serbia
Serbia Site
Singapore
Slovakia
South Africa
South Africa Site
Spain
Spain Site
Sri Lanka
Sweden
Sweden Site
Switzerland
Switzerland Site
Taiwan (China)
Taiwan (China) Site
Thailand
Trinidad & Tobago
Turkey
Turkey Site
Ukraine
United Arab Emirates
United Kingdom
United Kingdom Site
United States
United States Site
Uruguay
Venezuela
Vietnam
Yemen
Global / USA
Investors
Careers
Contact
Products
Key Therapeutic Areas
Central Nervous System
Key Products
BOTOX®
(onabotulinumtoxinA)
Product Details
BOTOX®
(onabotulinumtoxinA)
For Providers
Prescribing Information, including Boxed Warning
Medication Guide
Safety Data Sheet
For Patients
Patient Assistance Program
botox.com
NAMZARIC®
(memantine hydrochloride extended-release and donepezil hydrochloride) capsules, for oral use
Product Details
NAMZARIC®
(memantine hydrochloride extended-release and donepezil hydrochloride) capsules, for oral use
For Providers
Prescribing Information
Safety Data Sheet
For Patients
Patient Assistance Program
namzaric.com
VRAYLAR®
(cariprazine) capsules, for oral use
Product Details
VRAYLAR®
(cariprazine) capsules, for oral use
For Providers
Prescribing Information, including Boxed Warnings
Safety Data Sheet
For Patients
Patient Assistance Program
vraylar.com
All Central Nervous System Products
Eye Care
Key Products
LUMIGAN® 0.01%
(bimatoprost ophthalmic solution)
Product Details
LUMIGAN® 0.01%
(bimatoprost ophthalmic solution)
For Providers
Prescribing Information
For Patients
Patient Assistance Program
lumigan.com
OZURDEX®
(dexamethasone intravitreal implant) 0.7 mg
Product Details
OZURDEX®
(dexamethasone intravitreal implant) 0.7 mg
For Providers
Prescribing Information
Safety Data Sheet
ozurdex.com
REFRESH®
Portfolio of Consumer Eye Care Products
Product Details
REFRESH®
Portfolio of Consumer Eye Care Products
refreshbrand.com
RESTASIS®
(cyclosporine ophthalmic emulsion) 0.05%
Product Details
RESTASIS®
(cyclosporine ophthalmic emulsion) 0.05%
For Providers
Prescribing Information
Safety Data Sheet
For Patients
Patient Assistance Program
restasis.com
XEN® Gel Stent
glaucoma treatment system
Product Details
XEN® Gel Stent
glaucoma treatment system
For Providers
Directions for Use
XEN® 45 Voluntary Recall
xengelstent.com
All Eye Care Products
Gastroenterology
Key Products
LINZESS®
(linaclotide) capsules, for oral use
Product Details
LINZESS®
(linaclotide) capsules, for oral use
For Providers
Prescribing Information, including Boxed Warning
Safety Data Sheet
For Patients
Patient Assistance Program
linzess.com
VIBERZI®
(eluxadoline) tablets, for oral use, CIV
Product Details
VIBERZI®
(eluxadoline) tablets, for oral use, CIV
For Providers
Prescribing Information
Safety Data Sheet
For Patients
Patient Assistance Program
viberzi.com
ZENPEP®
(pancrelipase) delayed release capsules
Product Details
ZENPEP®
(pancrelipase) delayed release capsules
For Providers
Prescribing Information
Safety Data Sheet
For Patients
Patient Assistance Program
zenpep.com
All Gastroenterology Products
Medical Aesthetics
Key Products
BOTOX® Cosmetic
(onabotulinumtoxinA)
Product Details
BOTOX® Cosmetic
(onabotulinumtoxinA)
For Providers
Prescribing Information, including Boxed Warning
Medication Guide
Safety Data Sheet
botoxcosmetic.com
COOLSCULPTING®
Product Details
COOLSCULPTING®
coolsculpting.com
JUVÉDERM® Ultra
Product Details
JUVÉDERM® Ultra
For Providers
Directions for Use
For Patients
Patient Labeling
juvederm.com
SkinMedica®
Product Details
SkinMedica®
skinmedica.com
All Medical Aesthetics Products
Patient Assistance Programs
View All Products
About
About Allergan
About Allergan
News
Executive Leadership
Business Development
Supplier Relations
Patent Notices
Media Resources
Allergan For
Patients & Caregivers
Healthcare Providers
Investors
Careers
R&D
R&D Pipeline
Clinical Trials
Innovation
Pre-Approval Access
Responsibility
Responsibility at Allergan
Community
Environmental & Sustainability
Social Contract
Patient Safety & Product Quality
Healthcare Provider Partnerships & Payments
Alliance Advocacy Support
Public Policy
California Supply Chain Disclosure
Menu
Close
Global / USA
Home
Products
Key Therapeutic Areas
Central Nervous System
Eye Care
Gastroenterology
Medical Aesthetics
Patient Assistance Programs
View All Products
About
About Allergan
About Allergan
News
Executive Leadership
Business Development
Supplier Relations
Patent Notices
Media Resources
R&D
R&D Pipeline
Clinical Trials
Innovation
Pre-Approval Access
Responsibility
Responsibility at Allergan
Community
Environmental & Sustainability
Social Contract
Patient Safety & Product Quality
Healthcare Provider Partnerships & Payments
Alliance Advocacy Support
Public Policy
California Supply Chain Disclosure
Investors
Media
Patients
Providers
Careers
Contact
Central Nervous System
Key Products
View All Central Nervous System Products
BOTOX®
(onabotulinumtoxinA)
NAMZARIC®
(memantine hydrochloride extended-release and donepezil hydrochloride) capsules, for oral use
VRAYLAR®
(cariprazine) capsules, for oral use
Eye Care
Key Products
View All Eye Care Products
LUMIGAN® 0.01%
(bimatoprost ophthalmic solution)
OZURDEX®
(dexamethasone intravitreal implant) 0.7 mg
REFRESH®
Portfolio of Consumer Eye Care Products
RESTASIS®
(cyclosporine ophthalmic emulsion) 0.05%
XEN® Gel Stent
glaucoma treatment system
Gastroenterology
Key Products
View All Gastroenterology Products
LINZESS®
(linaclotide) capsules, for oral use
VIBERZI®
(eluxadoline) tablets, for oral use, CIV
ZENPEP®
(pancrelipase) delayed release capsules
Medical Aesthetics
Key Products
View All Medical Aesthetics Products
BOTOX® Cosmetic
(onabotulinumtoxinA)
COOLSCULPTING®
JUVÉDERM® Ultra
SkinMedica®
Investors
Investors
Events & Presentations
Corporate & Financial Information
Corporate Information:
Executives & Leadership
Corporate Governance
Committee Composition
Committee Charters
Acquisition of Allergan by AbbVie
Financials:
Annual Reports
Quarterly Results
SEC Filings
Insider Transactions
Proxy Materials
Shareholder Resources
Shareholder Services & Investor Kit
Information Request Form
Email Alerts
Dividends
Investor FAQ
Stock information
Stock Information
Stock Information
Historic Stock Look-Up
Analyst Coverage
Investment Calculator
Media
Media
Company Profile
Executive Bios & Photos
images
Videos
Patients
Patients
Providers
Providers
Medical Information Request
Careers
Careers
Search Careers
Live Boldly
Watch video
ALLERGAN FOR
Patients & Caregivers
Healthcare Providers
Your Career
Investors
PLAY VIDEO
STOP VIDEO
Mute Video
Unmute Video
Close Video
Acquisition of Allergan plc by AbbVie Inc.
BIOCELL® Product Safety Alert
Featured
Albert Yao: Sincerely Happy and Proud to see our Business Grow and Become a Leader
More News
Allergan Receives FDA Qualified Infectious Disease Product (QIDP) Designation And Fast Track Designation For ATM-AVI (Aztreonam And Avibactam) For Antibiotic-Resistant Gram-Negative Infections
Allergan Reports Third Quarter 2019 Financial Results
FDA Approves Medicines360’s LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Six Years, the Longest Approved Duration of Use of Any Hormonal IUDs
